Delivery Order SPE2DR25D2104-SPE2DR26F3TLA
- Not listed
- The Defense Logistics Agency (DLA) awarded a $13,511.84 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on September 12, 2025, with completion targeted for September 15, 2025. This firm fixed-price, non-set-aside contract represents a pediatric typhoid vaccine supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order as a delivery against...
- The Defense Logistics Agency (DLA) awarded a $100,185 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on December 16, 2025, with an ultimate completion date of December 17, 2025. This firm fixed-price contract represents a non-competitive delivery order placed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The product will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML vaccine syringes valued at $2,538.02 with a completion date of December 30, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed price delivery order structure, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $23,042.55 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on December 9, 2025, with an ultimate completion date of December 10, 2025. This non-competitive, firm fixed-price delivery order represents a single shipment of typhoid vaccine product for military or federal healthcare use. The contract is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company operates...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes valued at $10,793.90, with a completion date of December 17, 2025. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $1,961.71 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, a typhoid vaccine product. The order was competitively awarded without set-aside designation on January 7, 2026, with an ultimate completion date of January 8, 2026. Performance will occur at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s Indefinite...
- The Defense Logistics Agency awarded a $68,990 delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, a typhoid vaccine product. This firm fixed-price, competitively awarded contract was executed on September 22, 2025, with an ultimate completion date of September 23, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $3,339.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes, with an ultimate completion date of December 2, 2025. This is a non-set-aside contract, competitively awarded to the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The delivery order represents a child action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,576.50 to AmerisourceBergen Drug Corp for TYPHIM VI 25 MCG/0.5 ML syringes on January 9, 2026, with a completion date of January 12, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's parent entity, Cencora, Inc. (doing...
- The Defense Logistics Agency awarded a $16,581.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This non-competitive delivery order, which must be completed by June 20, 2025, represents a small-value procurement from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The contract is issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3TLADelivery Order
The Defense Logistics Agency (DLA) awarded a $14,306 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of TYPHIM VI 25 MCG/0.5 ML syringes. This non-competitive delivery order represents a single shipment of this typhoid vaccine product, with performance to be completed by January 14, 2026, and fulfillment occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement and holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical through December 2026, which provides the contracting vehicle for this and similar pharmaceutical and medical supply deliveries. This delivery order falls under AmerisourceBergen's larger pharmaceutical prime vendor agreement with the DLA, which enables the company to supply a comprehensive range of medications, vaccines, and medical commodities to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard. The contract reflects AmerisourceBergen's established role as a primary federal supplier for essential medical products across multiple therapeutic domains, with the firm fixed-price structure ensuring cost certainty for this vaccine procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.3k | 1/12/26 |